Market Cap 25.81M
Revenue (ttm) 1.76M
Net Income (ttm) -2.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.86%
Debt to Equity Ratio 0.00
Volume 152,400
Avg Vol 131,754
Day's Range N/A - N/A
Shares Out 11.57M
Stochastic %K 78%
Beta 0.43
Analysts Strong Buy
Price Target $5.00

Company Profile

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 561 961 1900
Address:
951 Yamato Road, Suite 220, Boca Raton, United States
Paper_Route_Frank
Paper_Route_Frank Jan. 17 at 1:22 PM
$TXMD avg 1.99 light position
0 · Reply
mwhite9869
mwhite9869 Jan. 17 at 12:28 AM
0 · Reply
mwhite9869
mwhite9869 Jan. 16 at 10:05 PM
$ATAI at this rate, my $TXMD position is going to be worth me than this. 🙄
0 · Reply
mwhite9869
mwhite9869 Jan. 16 at 9:46 PM
$TXMD this is at 2.39, why isn't it reflected on here?
0 · Reply
SteveBl
SteveBl Jan. 16 at 9:19 PM
$TXMD where is the ceiling on this thing?
1 · Reply
YPOJOB
YPOJOB Jan. 15 at 10:50 PM
$TXMD Lets do this again. And again. And again. Why not And again. Fun to see some movement.
0 · Reply
Chazzzz1
Chazzzz1 Jan. 15 at 7:41 PM
$TXMD Big Boys stepping it UP!
0 · Reply
jfer333
jfer333 Jan. 15 at 7:13 PM
$TXMD Is a Quiet Deal Brewing? No court docket updates since Oct 2nd. The judge referred Mayne’s motion to dismiss — but there’s been radio silence since. That could mean one thing: negotiations. 🕵️‍♂️ 3 Signs a Deal Might Be Close: 1️⃣ Joint motion to stay or extend → nothing yet, but it could drop soon. 2️⃣ Stipulated dismissal or settlement notice → often filed right before a deal is done. 3️⃣ Volume surge or insider buying → the quiet before the storm? TXMD may now have leverage with Mayne after the FIRB drama. Settlement could unlock value and clean the slate for what’s next. Just a theory. But the silence is starting to speak. 👀
3 · Reply
Kobe2324
Kobe2324 Jan. 14 at 12:36 AM
$TXMD can we get this thing wrapped up. It’s been two years of strategic alternatives. I know maybe and cosette messed things up but it’s time to move
2 · Reply
Chazzzz1
Chazzzz1 Jan. 10 at 1:59 AM
$TXMD Big Boys in Control. Watch for the news this weekend.
1 · Reply
Latest News on TXMD
TherapeuticsMD Announces Third Quarter 2025 Financial Results

Nov 12, 2025, 4:05 PM EST - 2 months ago

TherapeuticsMD Announces Third Quarter 2025 Financial Results


TherapeuticsMD Announces Second Quarter 2025 Financial Results

Aug 12, 2025, 4:05 PM EDT - 5 months ago

TherapeuticsMD Announces Second Quarter 2025 Financial Results


TherapeuticsMD Announces First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 8 months ago

TherapeuticsMD Announces First Quarter 2025 Financial Results


TherapeuticsMD Announces Full Year 2024 Financial Results

Mar 27, 2025, 4:05 PM EDT - 10 months ago

TherapeuticsMD Announces Full Year 2024 Financial Results


TherapeuticsMD Announces Third Quarter 2024 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

TherapeuticsMD Announces Third Quarter 2024 Financial Results


TherapeuticsMD Announces First Quarter 2024 Financial Results

May 10, 2024, 4:05 PM EDT - 1 year ago

TherapeuticsMD Announces First Quarter 2024 Financial Results


TherapeuticsMD Announces Full Year 2023 Financial Results

Mar 29, 2024, 4:00 PM EDT - 1 year ago

TherapeuticsMD Announces Full Year 2023 Financial Results


TherapeuticsMD Announces Third Quarter 2023 Financial Results

Nov 14, 2023, 4:05 PM EST - 2 years ago

TherapeuticsMD Announces Third Quarter 2023 Financial Results


TherapeuticsMD Announces Second Quarter 2023 Financial Results

Aug 14, 2023, 6:50 AM EDT - 2 years ago

TherapeuticsMD Announces Second Quarter 2023 Financial Results


TherapeuticsMD: From Fallen And Forgotten To Cash Cow

May 23, 2023, 9:00 AM EDT - 2 years ago

TherapeuticsMD: From Fallen And Forgotten To Cash Cow


TherapeuticsMD Announces First Quarter 2023 Financial Results

May 15, 2023, 4:05 PM EDT - 2 years ago

TherapeuticsMD Announces First Quarter 2023 Financial Results


TherapeuticsMD Announces Third Quarter 2022 Financial Results

Nov 14, 2022, 4:05 PM EST - 3 years ago

TherapeuticsMD Announces Third Quarter 2022 Financial Results


TherapeuticsMD Announces $7 Million Private Placement

Oct 3, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces $7 Million Private Placement


TherapeuticsMD Announces Second Quarter 2022 Financial Results

Aug 15, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Second Quarter 2022 Financial Results


Why TherapeuticsMD Shares Are Sinking Today?

Jul 13, 2022, 9:59 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Sinking Today?


TherapeuticsMD's stock falls 41% after tender offer expires

Jul 13, 2022, 8:25 AM EDT - 3 years ago

TherapeuticsMD's stock falls 41% after tender offer expires


TherapeuticsMD Announces Expiration of Tender Offer

Jul 13, 2022, 6:50 AM EDT - 3 years ago

TherapeuticsMD Announces Expiration of Tender Offer


Here is why TherapeuticsMD jumped 300%

May 31, 2022, 1:57 PM EDT - 3 years ago

Here is why TherapeuticsMD jumped 300%


Why TherapeuticsMD Stock Is Soaring Today

May 31, 2022, 10:12 AM EDT - 3 years ago

Why TherapeuticsMD Stock Is Soaring Today


Why TherapeuticsMD Shares Are Trading Higher Today

May 20, 2022, 10:54 AM EDT - 3 years ago

Why TherapeuticsMD Shares Are Trading Higher Today


TherapeuticsMD Announces First Quarter 2022 Financial Results

May 16, 2022, 4:05 PM EDT - 3 years ago

TherapeuticsMD Announces First Quarter 2022 Financial Results


TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

Mar 10, 2022, 6:50 AM EST - 4 years ago

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results


Why TherapeuticsMD Shares Are Soaring Today

Mar 7, 2022, 9:38 AM EST - 4 years ago

Why TherapeuticsMD Shares Are Soaring Today


Paper_Route_Frank
Paper_Route_Frank Jan. 17 at 1:22 PM
$TXMD avg 1.99 light position
0 · Reply
mwhite9869
mwhite9869 Jan. 17 at 12:28 AM
0 · Reply
mwhite9869
mwhite9869 Jan. 16 at 10:05 PM
$ATAI at this rate, my $TXMD position is going to be worth me than this. 🙄
0 · Reply
mwhite9869
mwhite9869 Jan. 16 at 9:46 PM
$TXMD this is at 2.39, why isn't it reflected on here?
0 · Reply
SteveBl
SteveBl Jan. 16 at 9:19 PM
$TXMD where is the ceiling on this thing?
1 · Reply
YPOJOB
YPOJOB Jan. 15 at 10:50 PM
$TXMD Lets do this again. And again. And again. Why not And again. Fun to see some movement.
0 · Reply
Chazzzz1
Chazzzz1 Jan. 15 at 7:41 PM
$TXMD Big Boys stepping it UP!
0 · Reply
jfer333
jfer333 Jan. 15 at 7:13 PM
$TXMD Is a Quiet Deal Brewing? No court docket updates since Oct 2nd. The judge referred Mayne’s motion to dismiss — but there’s been radio silence since. That could mean one thing: negotiations. 🕵️‍♂️ 3 Signs a Deal Might Be Close: 1️⃣ Joint motion to stay or extend → nothing yet, but it could drop soon. 2️⃣ Stipulated dismissal or settlement notice → often filed right before a deal is done. 3️⃣ Volume surge or insider buying → the quiet before the storm? TXMD may now have leverage with Mayne after the FIRB drama. Settlement could unlock value and clean the slate for what’s next. Just a theory. But the silence is starting to speak. 👀
3 · Reply
Kobe2324
Kobe2324 Jan. 14 at 12:36 AM
$TXMD can we get this thing wrapped up. It’s been two years of strategic alternatives. I know maybe and cosette messed things up but it’s time to move
2 · Reply
Chazzzz1
Chazzzz1 Jan. 10 at 1:59 AM
$TXMD Big Boys in Control. Watch for the news this weekend.
1 · Reply
YPOJOB
YPOJOB Jan. 10 at 1:36 AM
$TXMD Closed at 2.16. Wow. I hate saying this....but. " somebody knows something". Maybe its us!!
0 · Reply
JJYLT
JJYLT Jan. 9 at 8:24 PM
$TXMD great week.
0 · Reply
jfer333
jfer333 Jan. 9 at 2:53 PM
$TXMD do we get a court filing this evening? Could be a bullish move up if we go to trial.
0 · Reply
spanktown
spanktown Jan. 9 at 2:16 PM
$TXMD So their full year royalty take home for 2025 should be north of $5MM?? Just looking at $69+ million in net sales (based on previous Mayne full year report) at 8%?
1 · Reply
mwhite9869
mwhite9869 Jan. 9 at 2:09 PM
$TXMD I've been in and out of this stock so many times....I feel like maybe now it might pay off.
1 · Reply
h8ster
h8ster Jan. 6 at 10:39 PM
$TXMD I know I said lastly, but I lied. Let's not forget the probability of TXMD as a 2nd choice in the Cosette/Mayne buyout debacle. Cosette could take TXMD private simply for the royalties they would receive from Mayne Pharma licensing deal with TXMD, along with the included milestone payments. Had Cosette not been able to back out of the Mayne buyout deal, Cosette would have been the one paying TXMD those royalties and milestone payments from the agreement. In the course of their initial DD, when they first decided to buyout Mayne, Cosette had to of done extensive research on TXMD and the potential of it's major women's health products. Without any doubt, I believe TXMD is currently on Cosette's radar.
3 · Reply
h8ster
h8ster Jan. 6 at 10:32 PM
$TXMD Lastly. Here's an AI breakdown of all the main lower level bio companies that Rubric Capital (David Rosen) owns a bunch of, and would consider merging with TXMD and which is the best fit.
1 · Reply
h8ster
h8ster Jan. 6 at 10:08 PM
$TXMD Since Nov. 2023, Rubric has been stating that TXMD is actively exploring "strategic alternatives" explicitly including: Acquisitions Mergers Business combinations Asset sales Being that Rubric Cap is a fund and Rosen has major positions in other bio's such as HRTX, COLL & MREO, it seems likely he would merge TXMD with one of those. TXMD's growing royalties and milestones would supply much needed, non-dilutive capital for their pipelines. For me HRTX is the best candidate. They are a commercial stage bio, but are really not that profitable, yet, going through the growing pains of a small cap in a big boy market, but they are getting better. Adding TXMD's royalties and milestones could be the perfect bump up they need. Rosen owns 18% of the company, and of the 3, HRTX is in a position to where Rosen stands to benefit the most from a merger with TXMD. Its coming. Just a matter of when. Just gotta settle the royalty issues with Mayne, which are overdue.
1 · Reply
h8ster
h8ster Jan. 6 at 9:37 PM
$TXMD For those that don't know, TXMD is majority owned by Rubric Capital. Rubric Capital is run by David Rosen. David Rosen is the protege of Steven Cohen. Steven Cohen ran SAC Cap, now Point 72. David Rosen started Rubric as a side-bitch of SAC Cap and was given his own team $150M by Cohen to get it going. Eventually, the infamous SAC Cap and Cohen.....(FYI, Bobby Axelrod and his fund AXE Cap was based off of SAC Cap & Cohen).....was busted by the government for insider trading. The fund was disbanded and Cohen eventually went on to form Point 72. When SAC Cap was broken up, David Rosen had received Steven Cohen's blessing to take Rubric and make it his own individual fund. It is now a multi billion dollar fund. At the time, Steven Cohen & SAC Cap was considered the GOAT of bio investing. Everything they touched turned to gold, due to intense DD, and yes, insider trading Rosen knows whats up. Taught by the GOAT. TXMD is one of his babies. Big things are happening right now
1 · Reply
www_larval_com
www_larval_com Jan. 6 at 8:52 PM
$BIOA 8%[23%] $EMAT 8%[146%] $TGEN -6%[-21%] $TXMD 4%[16%] $YDES 3%[-5%] most notable movement into the final minutes of trading.
0 · Reply
jfer333
jfer333 Jan. 6 at 7:38 PM
$TXMD at the moment this is just a break out from a bull flag. Volume looks good but news brings volume. Volume brings a parabolic move up that will result in multiple halts. Ultimately getting news on this breakout will send it in epic fashion. Cmon Rubric.
1 · Reply
brenbto
brenbto Jan. 6 at 6:57 PM
$TXMD 52 week high
0 · Reply